Elironrasib is an investigational new drug that is being developed by REVOLUTION Medicines for the treatment of solid tumors. It is a RAS(ON) G12C-Selective KRAS inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.